Unusual 11 Mid-Day Movers 7/25: (S) (SPHS) (NPTN) Higher; (TBRA) (STRP) (TCCO) Lower
Tweet Send to a Friend
Tobira Therapeutics (Nasdaq: TBRA) 58.0% LOWER; announced results from CENTAUR, its Phase 2b clinical trial evaluating the efficacy and safety ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
